← Back to Clinical Trials
Recruiting NCT05725668

NCT05725668 A Study of Dual-task Exercise Training to Prevent Falls Among Older Adults With Mild Cognitive Impairment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05725668
Status Recruiting
Phase
Sponsor Oregon Research Institute
Condition Mild Cognitive Impairment
Study Type INTERVENTIONAL
Enrollment 336 participants
Start Date 2023-07-15
Primary Completion 2027-07-30

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age 95 Years
Study Type INTERVENTIONAL
Interventions
dual-task tai ji quanstandard tai ji quanstretching

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 336 participants in total. It began in 2023-07-15 with a primary completion date of 2027-07-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To determine the efficacy of a dual-task tai ji quan training therapy in reducing the incidence of falls in older adults with mild cognitive impairment.

Eligibility Criteria

Inclusion Criteria: * being 65 years and older * having complaint of memory loss * scoring ≤0.5 on Clinical Dementia Scale * having had 1 or more falls in the preceding 12 months or scoring ≥12 seconds on the Timed Up and Go test Exclusion Criteria: * scoring \<24 on the Mini-Mental State Examination * being able to ambulate independently for household distances * having medical clearance * having participated in any regular and structured tai ji quan-based exercise programs (≥2 times weekly) in the preceding 6 months * having a progressive neuromuscular disorder such as Parkinson's disease or multiple sclerosis * being unwilling to be randomized

Contact & Investigator

Central Contact

Fuzhong Li, Ph.D.

✉ fuzhongl@ori.org

📞 541-484-2123

Frequently Asked Questions

Who can join the NCT05725668 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, up to 95 Years, studying Mild Cognitive Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05725668 currently recruiting?

Yes, NCT05725668 is actively recruiting participants. Contact the research team at fuzhongl@ori.org for enrollment information.

Where is the NCT05725668 trial being conducted?

This trial is being conducted at Springfield, United States.

Who is sponsoring the NCT05725668 clinical trial?

NCT05725668 is sponsored by Oregon Research Institute. The trial plans to enroll 336 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology